THE NUCLEAR FACTOR κB (NFκB) AND NOTCH SIGNALLING PATHWAYS AND BRCA1 MRNA EXPRESSION IN STAGE IV NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS (P)

被引：0
|
作者：
Santarpia, Mariacarmela [1 ]
Sanchez-Ronco, Maria [2 ]
Magri, Ignacio
Angel Molina, Miguel
Viteri, Santiago
Costa, Carlota
Gasco, Amaya
Gonzalez-Cao, Maria
Mederos, Nuria
Salazar, Fernanda
Bertran-Alamillo, Jordi
Jimenez-Capitan, Ana
Altavilla, Giuseppe [1 ]
Benlloch, Susana
Yeste, Zaira
Aldeguer, Erika
Taron, Miquel [3 ]
Rosell, Rafael [3 ]
机构：
[1] Univ Hosp Policlin G Martino, Milan, Italy
[2] Univ Alcala de Henares, Alcala De Henares 99775, Spain
[3] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Badalona, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
NFkB; Notch pathways; Non-Small-Cell Lung Cancer; BRCA1 mRNA expression;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S993 / S994
页数：2
相关论文
共 50 条
  • [11] BRCA1: A New Genomic Marker for Non-Small-Cell Lung Cancer
    Reguart, Noemi
    Felipe Cardona, Andres
    Carrasco, Esther
    Gomez, Patricia
    Taron, Miquel
    Rosell, Rafael
    CLINICAL LUNG CANCER, 2008, 9 (06) : 331 - 339
  • [12] MRNa Levels and Genetic Status of Genes Involved in the Epidermal Growth Factor Receptor (EGFR) and the Nuclear Factor kB (NF-kB) Pathways in Metastatic Non-Small-Cell Lung Cancer (NSCLC) Patients (P)
    Rosell, R. R.
    Mariacarmela Santarpia, M. S.
    Sanchez Ronco, M. S. R. Maria
    Carlota Costa, C. C.
    Angel Molina-Vila, M. A. M. Miguel
    Ignacio Magri, I. M.
    Santiago Viteri, S. V.
    Amaya Gasco, A. G.
    Nuria Mederos, N. M.
    Miquel Taron, M. T.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S636 - S636
  • [13] HIGH MRNA EXPRESSION OF LMO4, A BRCA1 DOWNREGULATOR, CORRELATES WITH BETTER PROGNOSIS IN ERLOTINIB-TREATED NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS (P) WITH EGFR MUTATIONS
    Karachaliou, N.
    Costa, C.
    Gimenez-Capitan, A.
    Viteri, S.
    Gasco, A.
    Camps, C.
    Carcereny, E.
    Sureda, B. Massuti
    Souglakos, J.
    Rosell, R.
    ANNALS OF ONCOLOGY, 2012, 23 : 531 - 531
  • [14] PRETREATMENT EGFR T790M MUTATION AND BRCA1 MRNA EXPRESSION IN ERLOTINIB-TREATED ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS (P) WITH EGFR MUTATIONS
    Rosell, R.
    Molina, M. A.
    Costa, C.
    Bertran-Alamillo, J.
    Mayo, C.
    Moran, T.
    Viteri, S.
    Mendez, P.
    Benlloch, S.
    Taron, M.
    ANNALS OF ONCOLOGY, 2010, 21 : 129 - 129
  • [15] XPG mRNA Expression Levels Modulate Prognosis in Resected Non-Small-Cell Lung Cancer in Conjunction with BRCA1 and ERCC1 Expression
    Bartolucci, Roberta
    Wei, Jia
    Sanchez, Jose Javier
    Perez-Roca, Laia
    Chaib, Imane
    Puma, Francesco
    Farabi, Raffaele
    Mendez, Pedro
    Roila, Fausto
    Okamoto, Tatsuro
    Taron, Miquel
    Rosell, Rafael
    CLINICAL LUNG CANCER, 2009, 10 (01) : 47 - 52
  • [16] BRCA1, LMO4, and CtIP mRNA Expression in Erlotinib-Treated Non-Small-Cell Lung Cancer Patients with EGFR Mutations
    Karachaliou, Niki
    Costa, Carlota
    Gimenez-Capitan, Ana
    Angel Molina-Vila, Miguel
    Bertran-Alamillo, Jordi
    Mayo, Clara
    Massuti, Bartomeu
    Majem, Margarita
    Carcereny, Enric
    Moran, Teresa
    Javier Sanchez, Jose
    Viteri, Santiago
    Gasco, Amaya
    Wannesson, Luciano
    Souglakos, John
    Jimeno, Jose
    Rosell, Rafael
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (03) : 295 - 300
  • [17] Erlotinib customization based on epidermal growth factor receptor (EGFR) mutations in stage IV non-small-cell lung cancer (NSCLC) patients (p)
    Porta, R.
    Queralt, C.
    Cardenal, F.
    Mayo, C.
    Provencio, M.
    Camps, C.
    Isla, D.
    Gonzalez-Larriba, J.
    Taron, M.
    Rosell, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [18] A PHASE II STUDY OF FIRST-LINE BORTEZOMIB (B) IN PATIENTS (PTS) WITH STAGE IIIB/IV NON-SMALL-CELL LUNG CANCER (NSCLC)
    Planchard, D.
    Besse, B.
    Meric, J. B.
    Veillard, A. S.
    Pignon, J. P.
    Chan, K.
    Mathiot, C.
    Lumbroso, J.
    Lafontaine, C.
    Soria, J. C.
    ANNALS OF ONCOLOGY, 2008, 19 : 96 - 96
  • [19] Maintenance strategies in stage IV non-small-cell lung cancer (NSCLC): in which patients, with which drugs?
    Polo, V.
    Besse, B.
    ANNALS OF ONCOLOGY, 2014, 25 (07) : 1283 - 1293
  • [20] OUTCOME IN PEMETREXED/CISPLATIN-TREATED NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS ACCORDING TO MRNA EXPRESSION LEVELS OF BRCA1, TS, AEG1 AND REV3
    Massuti, Bartomeu
    Lopez-Vivanco, Guillermo
    Marti, Thomas M.
    Kotov, Ilya
    Chaib, Imane
    Ponce-Aix, Santiago
    Garcia-Campelo, Rosario
    Miguel Sanchez, Jose
    Artal, Angel
    Bover, Isabel
    Taron, Miquel
    Sanchez-Ronco, Maria
    Rolfo, Christian
    Stahel, Rolf
    Rosell, Rafael
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1040 - S1041
12345